Health Catalyst Stock (NASDAQ:HCAT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.71

52W Range

$0.95 - $4.20

50D Avg

$1.34

200D Avg

$2.20

Market Cap

$118.23M

Avg Vol (3M)

$1.23M

Beta

1.66

Div Yield

-

HCAT Company Profile


Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,500

IPO Date

Jul 25, 2019

Website

HCAT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Recurring Technology$208.28M$194.85M$187.23M
One-time Technology--$357.00K

Fiscal year ends in Dec 25 | Currency in USD

HCAT Financial Summary


Dec 25Dec 24Dec 23
Revenue$311.14M$306.58M$295.94M
Operating Income$-160.85M$-69.81M$-126.90M
Net Income$-177.97M$-69.50M$-118.15M
EBITDA$-143.16M$-10.65M$-68.28M
Basic EPS$-2.55$-1.15$-2.09
Diluted EPS$-2.55$-1.15$-2.09

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 11, 26 | 12:00 AM
Q4 25Mar 12, 26 | 5:00 PM
Q3 25Nov 10, 25 | 5:00 PM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health, Inc.
PYXSPyxis Oncology, Inc.
ENTAEnanta Pharmaceuticals, Inc.
NNOXNano-X Imaging Ltd.
TNYATenaya Therapeutics, Inc.
HSDTSolana Company
PRLDPrelude Therapeutics Incorporated
OBIOOrchestra BioMed Holdings, Inc.
OMOutset Medical, Inc.
CRBUCaribou Biosciences, Inc.